Genetics of ischemic stroke

Clinical and Experimental Hypertension

Volumn 24, Issue 7-8, 2002, Pages 531-534

  Venti, Michele ^a   Parnetti, Lucilla ^a   Gallai, Virgilio ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Nitric oxide production; Polymorphism; Renin angiotensin system

Indexed keywords

ANGIOTENSIN; NITRIC OXIDE; RENIN;

CARDIOVASCULAR AUTOREGULATION; CONFERENCE PAPER; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HEMOSTASIS; HUMAN; HYPERHOMOCYSTEINEMIA; LIPID METABOLISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STROKE;

BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; HEMOSTASIS; HOMOCYSTEINE; HUMANS; LIPID METABOLISM; LIPIDS; NITRIC OXIDE; POLYMORPHISM, GENETIC; PREVALENCE; RENIN-ANGIOTENSIN SYSTEM;

EID: 0036814739     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.1081/CEH-120015329     Document Type: Conference Paper

References (18)

1. Elbaz, A.; Amarenco, P. Genetic susceptibility and ischaemic stroke. Curr. Opin. Neurol. 1999, 12 (1), 47-55.
2. Hassan, A.; Markus, H.S. Genetics and ischaemic stroke. Brain. 2000, 123 (Pt 9):1, 784-812.
3. Kessler, C.; Spitzer, C.; Stauske, D.; Mende, S.; Stadmuller, J.; Walther, R. The apolipoprotein E and beta-fibrinogen G/A-455 gene polymorphisms are associated with ischemic stroke involving large vessel disease. Arterioscler. Thromb. Vasc. Biol. 1997, 17, 2880-2884.
4. Heywood, D.M.; Carter, A.M.; Catto, A.J.; Bamford, J.M.; Grant, P.J. Polymorphisms of the factor VII gene and circulating fvii:c levels in relation to acute cerebrovascular disease and poststroke mortality. Stroke 1997, 28 (4), 816-821.
5. Catto, A.J.; Carter, A.M.; Stickland, M.; Bamford, J.M.; Davies, J.A.; Grant, P.J. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphism and levels in subjects with cerebrovascular disease. Thromb. Haemost. 1997, 77 (4), 730-734.
6. Longstreth, W.T. Jr.; Rosendaal, F.R.; Siscovick, D.S.; Vos, H.L.; Schwartz, S.M.; Psaty, B.M.; Raghunathan, T.E.; Koepsell, T.D.; Reitsma, P.H. Risk of stroke in young women and two prothrombotic mutations, factor V leiden and prothrombin gene variant (G20210A). Stroke. 1998, 29 (3), 577-580.
7. Corral, J.; Gonzalez-Conejero, R.; Lozano, M.L.; Rivera, J.; Vicente, V. Genetic polymorphisms of factor VII are not associated with arterial thrombosis. Blood Coagul. Fibrinolysis. 1998, 9 (3), 267-272.
8. Catto, A.J.; Kohler, H.P.; Bannan, S.; Stickland, M.; Carter, A.; Grant, P.J. Factor XIII Val 34 Leu, a Novel association with primary intracerebral hemorrhage. Stroke. 1998, 29 (4), 813-816.
9. Carter, A.M.; Ossei-Gerning, N.; Grant, P.J. Platet glycoprotein IIIa P1A polymorphism in young man with myocardial infarction. Lancet. 1996, 348, 485-486.
10. Carter, A.M.; Catto, A.J.; Bamford, J.M.; Grant, P.J. Platelet GpIIIa P1A and Gp Ib variable number tandem repeat polymorphisms and markers of platelet activation in acute stroke. Arterioscler. Thromb. Vasc. Biol. 1998, 18 (7), 1124-1131.
11. Wagner, K.R.; Giles, W.H.; Johnson, C.J.; Ou, C.Y.; Bray, P.F.; Goldschmidt-Clermont, P.J.; Croft, J.B.; Brown, V.K.; Stern, B.J.; Feeser, B.R.; Buchholz, D.W.; Earley, C.J.; Macko, R.F.; McCarter, R.J.; Sloan, M.A.; Stolley, P.D.; Wityk, R.J.; Wozniak, M.A.; Price, T.R.; Kittner, S.J. Platelet glycoprotein receptor IIIa polymorphism P1A2 and ischemic stroke risk, the stroke prevention in young women study. Stroke. 1998, 29 (3), 581-585.
12. Cambien, F.; Poirier, O.; Lecerf, L.; Evans, A.; Cambou, J.P.; Arveiler, D.; Luc, G.; Bard, J.M.; Bara, L.; Ricard, S. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992, 359 (6396), 641-644.
13. Sharma, P. Meta-analysis of the ACE gene in ischaemic stroke. J. Neurol. Neurosurg. Psychiatry. 1998, 64 (2), 227-230.
14. MacLeod, M.J.; Dahiyat, M.T.; Cumming, A.; Meiklejohn, D.; Shaw, D.; St Clair, D. No association between Glu/Asp polymorphism of NOS3 gene and ischemic stroke. Neurology. 1999, 53 (2), 418-420.
15. Brattstrom, L.; Wilcken, D.E.; Ohrvik, J.; Brudin, L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease, the result of a meta-analysis. Circulation. 1998, 98 (23), 2520-2526.
16. McCarron, M.O.; Delong, D.; Alberts, M.J. APOE genotype as a risk factor for ischemic cerebrovascular disease, a meta-analysis. Neurology. 1999, 53 (6), 1308-1311.
17. Benlian, P., Aalto-Setala, K.; Dieplinger, H.; Hofker, M.; James, R.; Poledne, R.; Talmud, P.; Vilaro, S. European Lipoprotein Club, Report of the 21st Annual Conference, Tutzing, September 28-October 1, 1998. Atherosclerosis. 1999, 144 (2), 449-458.
18. Huang, P.; Kostulas, K.; Huang, W.X.; Crisby, M.; Kostulas, V.; Hillert, J. Lipoprotein lipase gene polymorphisms in ischaemic stroke and carotid stenosis. Eur. J. Clin. Invest. 1997, 27 (9), 740-742.